OPEN ACCESS CLINIC PROVIDING HIV-I ANTIBODY RESULTS ON DAY OF TESTING - THE 1ST 12 MONTHS

被引:25
作者
SQUIRE, SB
ELFORD, J
BOR, R
TILSED, G
SALT, H
BAGDADES, EK
JANOSSY, G
GRIFFITHS, PD
JOHNSON, MA
机构
[1] Royal Free Hospital
关键词
D O I
10.1136/bmj.302.6789.1383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives - To determine the sociodemographic profile, risk category, and prevalence of HIV-1 infection among people attending a clinic providing counselling, medical advice, and results of HIV-1 antibody testing on the day of consultation; to determine the stage of infection and peripheral blood CD4 cell count among attenders with detectable HIV-1 antibodies. Design - Analysis of prospectively collected data for the 12 months from March 1989. Setting - Same day testing clinic run by the HIV/AIDS team at an urban teaching hospital. Patients - 561 consecutive people choosing to attend and proceeding to HIV-1 testing. Results - The demand for the service caused it to run to capacity within six months. The median age of those attending was 28 years and 65% (364 patients) were male. The overall prevalence of HIV-1 infection was 3.9% (22 patients). The greatest prevalence was in men reporting their primary risk as homosexual contact (11.9%, 13/109. The median CD4 cell count in the 22 patients who had detectable HIV-1 antibodies was 0.31 X 10(9) cells/l (normal range 0.5 X l0(9)/l to 1.2 X l0(9)/l). Twenty of these patients were asymptomatic (Centers for Disease Control stages 11 or 111), 14 had CD4 cell counts below 0.5 X l0(9)/l. Conclusions - There is a recognisable demand for a service providing rapid results of HIV-1 antibody testing in this setting. The overall seroprevalence of 3.9% is comparable with the 5.8% reported from freestanding clinics in the United States. Most patients with HIV-I antibodies detected in this way are asymptomatic but could benefit from early medical intervention because of low CD4 cell counts.
引用
收藏
页码:1383 / 1386
页数:4
相关论文
共 17 条
  • [1] HIV TESTING - CHANGING TRENDS AT A CLINIC FOR SEXUALLY-TRANSMITTED DISEASES IN LONDON
    BECK, EJ
    CUNNINGHAM, DG
    MOSS, VW
    HARRIS, JRW
    PINCHING, AJ
    JEFFRIES, DJ
    [J]. BRITISH MEDICAL JOURNAL, 1987, 295 (6591) : 191 - 193
  • [2] SAFETY AND EFFICACY OF SULFAMETHOXAZOLE AND TRIMETHOPRIM CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS
    FISCHL, MA
    DICKINSON, GM
    LAVOIE, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (08): : 1185 - 1189
  • [3] THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISCHL, MA
    RICHMAN, DD
    HANSEN, N
    COLLIER, AC
    CAREY, JT
    PARA, MF
    HARDY, WD
    DOLIN, R
    POWDERLY, WG
    ALLAN, JD
    WONG, B
    MERIGAN, TC
    MCAULIFFE, VJ
    HYSLOP, NE
    RHAME, FS
    BALFOUR, HH
    SPECTOR, SA
    VOLBERDING, P
    PETTINELLI, C
    ANDERSON, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) : 727 - 737
  • [4] GREEN J, 1987, CURRENT TOPICS AIDS, V1, P287
  • [5] HIV WITH REDUCED SENSITIVITY TO ZIDOVUDINE (AZT) ISOLATED DURING PROLONGED THERAPY
    LARDER, BA
    DARBY, G
    RICHMAN, DD
    [J]. SCIENCE, 1989, 243 (4899) : 1731 - 1734
  • [6] LO B, 1989, ANN INTERN MED, V110, P727
  • [7] CD4 COUNTS AS PREDICTORS OF OPPORTUNISTIC PNEUMONIAS IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
    MASUR, H
    OGNIBENE, FP
    YARCHOAN, R
    SHELHAMER, JH
    BAIRD, BF
    TRAVIS, W
    SUFFREDINI, AF
    DEYTON, L
    KOVACS, JA
    FALLOON, J
    DAVEY, R
    POLIS, M
    METCALF, J
    BASELER, M
    WESLEY, R
    GILL, VJ
    FAUCI, AS
    LANE, HC
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (03) : 223 - 231
  • [8] NATURAL-HISTORY OF HIV INFECTION
    MOSS, AR
    BACCHETTI, P
    [J]. AIDS, 1989, 3 (02) : 55 - 61
  • [9] MURPHY FA, 1989, MMWR S5, V38, pS1
  • [10] PHILLIPS AN, 1991, LANCET, V337, P389